| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |